Chloe M. Chhor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chloe M. Chhor has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Cecilia L. Mercado
Department of Radiology, New York University School of Medicine, 221 Lexington Ave, New York, NY 10016
2 shared publications- Cecilia L. Mercado
Department of Radiology, NYU School of Medicine, NYU Langone Medical Center, 550 First Ave., New York, NY 10016, USA
2 shared publications - Osvaldo Hernandez
Department of Pathology, New York University Langone Medical Center, New York, NY, USA
2 shared publications - Shimwoo Lee
NYU School of Medicine, NYU Langone Medical Center, 550 First Ave., New York, NY 10016, USA
2 shared publications Adrienne Newburg
University of Massachusetts Medical School, UMass Memorial Medical Center
1 shared publication- Akshat C. Pujara
Department of Radiology, New York University School of Medicine, New York, New York, USA
1 shared publication
Latest Publications
- 1 July 2018
- Published by Elsevier in Clinical Imaging
- Vol. 50, 31-36
Frequency and outcomes of biopsy-proven fibroadenomas recommended for surgical excision
- 1 July 2018
- Published by Elsevier in Clinical Imaging
- Vol. 50, 31-36
Frequency and outcomes of biopsy-proven fibroadenomas recommended for surgical excision
- 1 February 2018
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 210 (2) , 246-255
Ductal Carcinoma In Situ: The Whole Truth
OBJECTIVE. Ductal carcinoma in situ (DCIS) is a noninvasive malignant breast disease traditionally described as a precursor lesion to invasive breast cancer. With screening mammography, DCIS now accounts for approximately 20% of newly diagnosed cancer cases. DCIS is not well understood because of its heterogeneous nature. CONCLUSION. Studies have aimed to assess prognostic factors to characterize its risk of invasive potential; however, there still remains a lack of uniformity in workup and treatment. We summarize current knowledge of DCIS and the ongoing controversies.
- 1 February 2018
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 210 (2) , 246-255
Ductal Carcinoma In Situ: The Whole Truth
OBJECTIVE. Ductal carcinoma in situ (DCIS) is a noninvasive malignant breast disease traditionally described as a precursor lesion to invasive breast cancer. With screening mammography, DCIS now accounts for approximately 20% of newly diagnosed cancer cases. DCIS is not well understood because of its heterogeneous nature. CONCLUSION. Studies have aimed to assess prognostic factors to characterize its risk of invasive potential; however, there still remains a lack of uniformity in workup and treatment. We summarize current knowledge of DCIS and the ongoing controversies.
- 1 March 2017
- Published by Elsevier in Clinical Imaging
- Vol. 42, 119-125
Clinical applicability and relevance of fibroglandular tissue segmentation on routine T1 weighted breast MRI
- 1 March 2017
- Published by Elsevier in Clinical Imaging
- Vol. 42, 119-125
Clinical applicability and relevance of fibroglandular tissue segmentation on routine T1 weighted breast MRI
- 1 March 2017
- Published by Elsevier in Clinical Imaging
- Vol. 42, 88-92
Metastatic carcinoid tumor to the breast: report of two cases and review of the literature
- 1 March 2017
- Published by Elsevier in Clinical Imaging
- Vol. 42, 88-92
Metastatic carcinoid tumor to the breast: report of two cases and review of the literature
- 28 February 2017
- Published by Springer Nature
- p. 221-232
Targeted Ultrasound After MRI
- 1 February 2017
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 208 (2) , 284-289
Abbreviated MRI Protocols: Wave of the Future for Breast Cancer Screening
OBJECTIVE. The purpose of this article is to describe the use of abbreviated breast MRI protocols for improving access to screening for women at intermediate risk. CONCLUSION. Breast MRI is not a cost-effective modality for screening women at intermediate risk, including those with dense breast tissue as the only risk. Abbreviated breast MRI protocols have been proposed as a way of achieving efficiency and rapid throughput. Use of these abbreviated protocols may increase availability and provide women with greater access to breast MRI.
- 1 February 2017
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 208 (2) , 284-289
Abbreviated MRI Protocols: Wave of the Future for Breast Cancer Screening
OBJECTIVE. The purpose of this article is to describe the use of abbreviated breast MRI protocols for improving access to screening for women at intermediate risk. CONCLUSION. Breast MRI is not a cost-effective modality for screening women at intermediate risk, including those with dense breast tissue as the only risk. Abbreviated breast MRI protocols have been proposed as a way of achieving efficiency and rapid throughput. Use of these abbreviated protocols may increase availability and provide women with greater access to breast MRI.
- 1 May 2015
- Published by Elsevier in Clinical Imaging
- Vol. 39 (3) , 339-343
Polyacrylamide gel breast augmentation: report of two cases and review of the literature
- 1 May 2015
- Published by Elsevier in Clinical Imaging
- Vol. 39 (3) , 339-343
Polyacrylamide gel breast augmentation: report of two cases and review of the literature